Growing community of inventors

Dalian, China

Min Hui

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Min HuiLi Fu (3 patents)Min HuiKaiqian Wang (3 patents)Min HuiShuo Wang (3 patents)Min HuiQiang Fu (2 patents)Min HuiYang Liu (2 patents)Min HuiZhengxian Liu (2 patents)Min HuiXin Gai (2 patents)Min HuiHongying Qu (2 patents)Min HuiXiaojing Yu (2 patents)Min HuiMingming Lu (2 patents)Min HuiHailing Wang (2 patents)Min HuiHongyu Fan (1 patent)Min HuiFan Li (1 patent)Min HuiQiang Fu (1 patent)Min HuiFan Li (0 patent)Min HuiYang Liu (0 patent)Min HuiMin Hui (3 patents)Li FuLi Fu (13 patents)Kaiqian WangKaiqian Wang (5 patents)Shuo WangShuo Wang (4 patents)Qiang FuQiang Fu (76 patents)Yang LiuYang Liu (8 patents)Zhengxian LiuZhengxian Liu (4 patents)Xin GaiXin Gai (3 patents)Hongying QuHongying Qu (2 patents)Xiaojing YuXiaojing Yu (2 patents)Mingming LuMingming Lu (2 patents)Hailing WangHailing Wang (2 patents)Hongyu FanHongyu Fan (4 patents)Fan LiFan Li (1 patent)Qiang FuQiang Fu (1 patent)Fan LiFan Li (0 patent)Yang LiuYang Liu (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (3 from 832,843 patents)

2. Fu, Li (0 patent)


3 patents:

1. 10881679 - Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

2. 10675317 - Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health care product for treating cytomegalovirus infection disorders

3. 10286002 - Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…